英国全国经验:初次植入瓣膜类型对主动脉瓣再手术的影响
该英国全国回顾性队列研究基于NICOR数据库,纳入1996至2019年首次孤立主动脉瓣再手术患者,比较机械瓣与生物瓣再手术结局。倾向性评分匹配后各324例,院内死亡率机械瓣7.1% vs 生物瓣5.9%(P=0.632),瓣膜类型非死亡危险因素(OR 0.62,95%CI 0.37-1.05;P=0.1)。年龄、左心室射血分数、肌酐≥200 mg/dl和心内膜炎为死亡危险因素。
要点
- 再手术时原瓣膜类型(机械瓣或生物瓣)不影响院内死亡率。
- 匹配后院内死亡率机械瓣7.1% vs 生物瓣5.9%,差异无统计学意义。
- 年龄、左心室射血分数、肌酐≥200 mg/dl和心内膜炎为院内死亡危险因素。
核心结论
- 初次植入的瓣膜类型(机械瓣或生物瓣)不决定再手术的院内死亡率。
- 年龄、左心室射血分数、肾功能不全和心内膜炎是院内死亡的显著危险因素。
研究设计与样本
- 英国全国回顾性队列研究,数据源自国家心血管结局研究(NICOR)数据库。
- 纳入1996至2019年英国首次孤立主动脉瓣再手术患者,排除合并手术、同种移植物植入或主动脉根部扩大者。
- 共2371例,其中初次手术植入机械瓣24.9%、生物瓣75%;采用倾向性评分匹配比较结局。
主要发现
- 倾向性评分匹配后机械瓣组与生物瓣组各324例。
- 院内死亡率机械瓣组7.1% vs 生物瓣组5.9%(P=0.632)。
- 多变量逻辑回归显示瓣膜类型非死亡危险因素(OR 0.62,95%CI 0.37-1.05;P=0.1)。
- 年龄(OR 1.03,95%CI 1.01-1.05;P<0.05)、左心室射血分数(OR 1.62,95%CI 1.08-2.42;P<0.05)、肌酐≥200 mg/dl(OR 2.21,95%CI 1.17-4.04;P<0.05)和心内膜炎(OR 2.66,95%CI 1.71-4.14;P<0.05)为死亡危险因素。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This nationwide retrospective cohort study assessed the impact of the explanted valve type on reoperative outcomes in aortic valve surgery within the UK over a 23-year period. METHODS: Data were sourced from the National Institute for Cardiovascular Outcomes Research (NICOR) database. All patients undergoing first-time isolated reoperative aortic valve replacement between 1996 and 2019 in the UK were included. Concomitant procedures, homograft implantation or aortic root enlargement were excluded. Propensity score matching was utilized to compare outcomes and risk factors for in-hospital mortality was evaluated through multivariable logistic regression. Final model selection was conducted using Akaike Information Criterion through bootstrapping. The primary end point was in-hospital mortality, and secondary end points included postoperative morbidities. RESULTS: Out of 2371 patients, 24.9% had mechanical and 75% had bioprosthetic valves implanted during the primary procedure. Propensity matched groups of 324 patients each, were compared. In-hospital mortality for mechanical and bioprosthetic valve explants was 7.1% and 5.9%, respectively (P = 0.632). On multivariable logistic regression analysis, valve type was not a risk factor for mortality [odds ratio (OR) 0.62, 95% confidence interval (CI) 0.37-1.05; P = 0.1]. Age (OR 1.03, 95% CI 1.01-1.05; P < 0.05), left ventricular ejection fraction (OR 1.62, 95% CI 1.08-2.42; P < 0.05), creatinine ≥ 200 mg/dl (OR 2.21, 95% CI 1.17-4.04; P < 0.05) and endocarditis (OR 2.66, 95% CI 1.71-4.14; P < 0.05) emerged as risk factors for mortality. CONCLUSIONS: The type of valve initially implanted (mechanical or bioprosthetic) did not determine mortality. Instead, age, left ventricular ejection fraction, renal impairment and endocarditis were significant risk factors for in-hospital mortality.
引用
- Narayan P, Dong T, Dimagli A, et al. Impact of explanted valve type on aortic valve reoperations: nationwide UK experience. Eur J Cardiothorac Surg. 2024. PMID: 38305431. doi:10.1093/ejcts/ezae031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。